These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 17065704

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors.
    Mostafa A, Mohamed MK, Saeed M, Hasan A, Fontanet A, Godsland I, Coady E, Esmat G, El-Hoseiny M, Abdul-Hamid M, Hughes A, Chaturvedi N.
    Gut; 2010 Aug; 59(8):1135-40. PubMed ID: 20584782
    [Abstract] [Full Text] [Related]

  • 4. Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesis.
    Lecube A, Hernández C, Genescà J, Simó R.
    Diabetes Care; 2006 May; 29(5):1140-9. PubMed ID: 16644655
    [No Abstract] [Full Text] [Related]

  • 5. Specific phenotype associated with diabetes mellitus secondary to chronic hepatitis C infection.
    Poussier A, Lebouvier M, Penfornis A, Di Martino V, Buffier P, Verges B, Hillon P, Petit JM.
    Diabet Med; 2008 Oct; 25(10):1237-40. PubMed ID: 19046205
    [Abstract] [Full Text] [Related]

  • 6. Glucose abnormalities are an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.
    Lecube A, Hernández C, Simó R, Esteban JI, Genescà J.
    Am J Gastroenterol; 2007 Oct; 102(10):2189-95. PubMed ID: 17617205
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
    Imazeki F, Yokosuka O, Fukai K, Kanda T, Kojima H, Saisho H.
    Liver Int; 2008 Mar; 28(3):355-62. PubMed ID: 18290778
    [Abstract] [Full Text] [Related]

  • 8. Uncovering glucose abnormalities in people with hepatitis C infection: should oral glucose tolerance test become a standard of care?
    Aytaman A, McFarlane SI.
    Am J Gastroenterol; 2008 Aug; 103(8):1941-3. PubMed ID: 18796093
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of hepatitis C in Swedish diabetics is low and comparable to that in health care workers.
    Sjöberg K, Widell A, Verbaan H.
    Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):135-8. PubMed ID: 18188035
    [Abstract] [Full Text] [Related]

  • 10. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W, Al-Nakib W.
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [Abstract] [Full Text] [Related]

  • 11. Re: renal involvement in patients with hepatitis C virus infection.
    Einollahi B.
    Iran J Kidney Dis; 2010 Jul; 4(3):270-1. PubMed ID: 20622322
    [No Abstract] [Full Text] [Related]

  • 12. Unveiling glucose abnormalities in patients with chronic hepatitis C infection.
    Yeh ML, Huang JF, Yu ML, Dai CY, Chuang WL.
    Am J Gastroenterol; 2009 Apr; 104(4):1051; author reply 1052. PubMed ID: 19277032
    [No Abstract] [Full Text] [Related]

  • 13. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case-control study. Response to Lecube et al.
    Petit JM, Minello A, Texier V, Hillon P.
    Diabetes Care; 2006 Sep; 29(9):2180; author reply 2180-1. PubMed ID: 16936179
    [No Abstract] [Full Text] [Related]

  • 14. Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload.
    Lecube A, Hernández C, Simó R.
    Diabetes Metab Res Rev; 2009 Jul; 25(5):403-10. PubMed ID: 19444865
    [Abstract] [Full Text] [Related]

  • 15. Doubts on the diagnosis of type 2 diabetes in patients with hepatitis C virus infection.
    Skowroński M, Zozulińska D, Juszczyk J, Wierusz-Wysocka B.
    Diabetes Res Clin Pract; 2006 Aug; 73(2):221-2. PubMed ID: 16616968
    [No Abstract] [Full Text] [Related]

  • 16. Hepatitis C is associated with type 2 diabetes mellitus in HIV-infected persons without traditional risk factors.
    Jain MK, Aragaki C, Fischbach L, Gibson S, Arora R, May L, Vardhineni K, Lee WM.
    HIV Med; 2007 Nov; 8(8):491-7. PubMed ID: 17944681
    [Abstract] [Full Text] [Related]

  • 17. [Endocrine disorders in HCV infection].
    Piszko P, Fleischer K, Simon K, Serafińska S.
    Przegl Epidemiol; 2006 Nov; 60(4):707-14. PubMed ID: 17682752
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis C and diabetes: the inevitable coincidence?
    Lonardo A, Adinolfi LE, Petta S, Craxì A, Loria P.
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):293-308. PubMed ID: 19344243
    [Abstract] [Full Text] [Related]

  • 19. [Hepatitis c virus and type 2 diabetes mellitus].
    Guglielmi V, Tutino M, Guerra V.
    Minerva Med; 2007 Feb; 98(1):1-4. PubMed ID: 17372576
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis C virus and glucose and lipid metabolism.
    Alaei M, Negro F.
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):692-700. PubMed ID: 19195632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.